SCHEMBL7322972

SCHEMBL7322972

O=C(O)c1cccc2c1OCCCC2

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.58
GFER P55789 1/20 0.41
RORC P51449 1/20 0.40
CXCR5 P32302 1/20 0.40
FABP4 P15090 2/20 0.38
BCL2L1 Q07817 1/20 0.38
BAD Q92934 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ALOX15 P16050 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7471201 0.98 PARP1 (0.57) PARP1GFERRORCCXCR5FABP4
SCHEMBL984448 0.95 PARP1 (0.60) PARP1GFERRORCCXCR5ALDH1A1
SCHEMBL30251654 0.95 PARP1 (0.60) PARP1GFERRORCCXCR5ALDH1A1
SCHEMBL729580 0.88 PARP1 (0.74) PARP1RORCFABP4ALDH1A1ALOX15
Hydrochloric Acid SCHEMBL7265489 0.86 PARP1 (0.72) PARP1RORCFABP4ALDH1A1ALOX15
SCHEMBL17978285 0.80 PARP1 (0.84) PARP1ALOX15
SCHEMBL18665581 0.80 PARP1 (0.58) PARP1ALDH1A1
Hydrochloric Acid SCHEMBL17978158 0.79 PARP1 (0.81) PARP1ALOX15
SCHEMBL11094419 0.77 PARP1 (0.49) PARP1ALDH1A1ALOX15
SCHEMBL21316384 0.76 PARP1 (0.54) PARP1MEN1KMT2AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4924010-A GASTROINTESTINAL DISORDERS RORER PHARMACEUTICAL CORPORATION (US) 1990-05-08 US disclosed
US-4859683-A Certain benzoxepins and their pharmaceutical compositions and methods RORER PHARMACEUTICAL CORPORATION (US) 1989-08-22 US disclosed
US-4857517-A Quinuclidyl benzoxepins as 5-HT3 antagonists RORER PHARMACEUTICAL CORPORATION (US) 1989-08-15 US disclosed